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The 2013 Nobel Prize in Chemistry has been awarded to Martin Karplus, Michael Levitt, and Arieh Warshel
for their work on developing computational methods to study complex chemical systems. Their work has
led to mechanistic critical insights into chemical systems both large and small and has enabled progress
in a number of different fields, including structural biology.Structure determines function! For de-
cades, this has been the mantra of biolo-
gists worldwide. For molecular biologists,
since the solving of the quintessential
double helix, the serial revelations of
awe-inspiring atomic-detail architectures
have done little to dissipate this struc-
ture-function frenzy. And yet, even from
the epoch of the first protein structures
from X-ray crystallography in the 1960s,
experimentalists have always known that
their static structures are not enough.
Structure can only ever serve as a starting
point to understanding biology. It has long
been obvious to all that biomolecules
must move to perform their functions
(‘‘Eppur si muove!’’ [And yet it does
move! (Galileo Galilei)]). Energies and
forces are what form structure and drive
the thermodynamics and dynamical
motions that underlie biological function.
Thus, to understand and comprehend
howmacromolecules work, one must ulti-
mately be able to ‘‘visualize’’ the manner
in which these complex nanoscale
‘‘molecular machines’’ move and change
their shape atom-by-atom as a function
of time as they perform their activities.
The problem, however, is that the three-
dimensional architectures provided by
the major atomic-resolution structural
techniques tell us nothing about the
energies and forces involved. In order to
quantify dynamics, some way to asso-
ciate energies and forces with molecular
geometry was urgently needed. The
solution to this problem, largely built
around the pioneering work of the three
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in the computer to simulate molecular
dynamics.
Transformative research can best be
appreciated with long hindsight, and
although this luxury is not often afforded
at the time of the Nobel award, this year’s
prize gives us this pleasure. The ‘‘origins’’
of the field are, of course, arbitrary
to define, but might pragmatically be
placed in the 1940s–1950s, with the first
computational molecular dynamics simu-
lations and the development of spectro-
scopic force fields to interpret infrared
and Raman spectra. Also progressing
was the field of the previous chemistry
‘‘theory’’ Nobel prize, awarded in 1998,
of quantum chemistry. Although not
always yielding quantitatively correct
results, quantum chemistry does provide
a relatively consistent framework for
looking at molecules, and, in contrast to
biomolecular simulation, the associated
computer programs, with their limited
functionality, are, in the main, arguably
hard to use incorrectly. However, accu-
rate quantum chemistry scales atro-
ciously with the number of electrons
involved, a challenge that may never be
overcome without discovering an alter-
native, computationally-tractable, theo-
retical route for electronic structure
calculations. Hence, to tackle large
interesting biomolecular systems, a large
helping of empiricism was needed, and
‘‘molecular mechanics’’ was born.
The middle and late 1960s found all
three future Nobelists influenced by
Schneior Lifson at theWeizmann Institute,Elsevier Ltd All rights reservedwho was developing ideas for using
molecular mechanics empirical functions
to calculate the energies of large mole-
cules. The novel idea was to use a func-
tional form that could serve not only
for calculating vibrational frequencies,
as did the spectroscopic force fields
using expansions of the potential about
a minimum-energy structure, but also for
determining that structure. The so-called
‘‘consistent force field’’ (CFF) of Lifson
and his coworkers, particularly Warshel,
included nonbonded interaction terms
so that the minimum-energy structure
could be found after the energy terms
had been appropriately calibrated. The
possibility of using such energy func-
tions for larger systems was becoming
apparent at that time, and Levitt and
Lifson pioneered the calculation of the
energy of a protein from atomic coordi-
nates (Levitt and Lifson, 1969).
The 2013 Nobel citation specifically
focused on a form of multiscale modeling
in which calculation of the energy of a
real system, such as an enzyme, is
performed by combining molecular
mechanics modeling of the environment
with quantum chemical modeling of the
core region (such as the active site) in
which the chemically interesting action
takes place. An important step was taken
when Warshel visited Karplus at Harvard
in the beginning of the 1970s. They con-
structed a computer program that used
a hybrid method combining classical
and quantum mechanics to describe
the p-electron and vibrational spectra of
a number of planar molecules (Warshel
Figure 1. Biomolecular Simulation Systems
in the 1970s and Now
(A) Bovine pancreatic trypsin inhibitor: the subject
of the first published MD simulation of a protein
(McCammon et al., 1977).
(B) Modern-day multimillion-atom simulation
model of lignocellulosic biomass with cellulose
(green), lignin (brown), and hemicellulose (green
strands).
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shel and Levitt constructed a more
general scheme for a partitioning between
electrons that are included in the classical
modeling and those that are explicitly
described by a quantum chemical model.
They reported this in their study of
the ‘‘Dielectric, Electrostatic and Steric
Stabilisation of the Carbonium Ion in the
Reaction of Lysozyme’’ (Warshel and
Levitt, 1976). These techniques initiated
what, today, is known as the ‘‘QM/MM’’
approach, which combines quantum
mechanics with molecular mechanical
modeling and is widely used to under-
stand enzyme reactions. The original
work at Harvard involved calculating the
vibronic spectra of retinal and related
molecules. Retinal, of course, is the chro-
mophore in the light-driven proton pump
protein, bacteriorhodopsin, and this
work illustrates nicely the convergence
of broad goals in structural biology and
computational chemistry. At around the
same time as the pioneering QM/MM
polyene calculations, efforts were being
made to obtain the first high-resolution
structure of a membrane protein, using
none other than bacteriorhodopsin itself.QM/MM was one of many creative
ideas in biomolecular modeling, and
simulation from the three laureates in the
1960s and 1970s seeded much of what
is possible today. However, although
important, QM/MM is only one area of
activity of the three winners, and the
2013 Nobel prize is therefore seen by
many also as recognition of the numerous
other critical contributions of the three as
well as recognition of the field of biomole-
cular simulation as a whole.
In large part, the conceptual contribu-
tion of biomolecular simulation relates
to dynamics. In a CECAM workshop at
Orsay in 1976, calculations were per-
formed by Andrew McCammon, leading
to the first publication with Bruce Gelin
and Martin Karplus of a molecular dy-
namics (MD) simulation of a protein
(McCammon et al., 1977). These CECAM
workshops were opportunities for very
fertile discussion and exchange among
scientists, and it is clear that a number
of people at the time contributed to the
ideas that led to ‘‘molecular dynamics’’
simulations of biological macromole-
cules. One name that particularly comes
to mind is Aneesur Rahman, who had
been the first to carry out MD simulations
of liquids using realistic models (Rahman,
1964). The subject of the 1976 calculation
was the small protein BPTI (Figure 1A),
simulated in vacuum for a fleeting 9 ps.
Although crude and short by modern
standards, this simulation arguably
changed mindsets, ushering in the era
of the dynamic protein. One of the
major conclusions was that the internal
motion of the protein is fluid-like at room
temperature, and much subsequent re-
search has concentrated on the com-
parison between this fluid-like physiolog-
ical state and the glass-like state of
proteins at low temperatures. Even to
this day, the mere suggestion that pro-
teins might display any fluid- or liquid-
like dynamics on such a short timescale
and lengthscale provokes the ire of
some crystallographers.
However, MD suffers from statistical
convergence problems and force field
errors, and, in years ensuing from the
first simulation, its use in structure predic-
tion was found to be equivocal. Levitt
himself referred to the use of molecular
mechanics in structure refinement of
homology models as ‘‘the central embar-
rassment of molecular mechanics, namelyStructure 21, December 3, 2013that energy minimization or molecular
dynamics generally leads to a model that
is less like the experimental structure’’
(Koehl and Levitt, 1999). Many of the cal-
culations performed were, and often are,
wrong, inconsistent, and biased and
disagree with experiment. Such short-
comings were assailed by solid, depend-
able structuralists. ‘‘It’s all rubbish!’’ was
the opinion of biomolecular modeling
and simulation expressed in the 1990s
to one of the present authors by
the director of a prestigious experimental
structural biology laboratory. Although
clearly rather a generalization, this opinion
was perhaps forgivable, given that model-
ing papers had just been published on the
critic’s own favorite system in which the
active site structure had been completely
massacred. To this day, harsh opinions
about the field are still encountered,
although perhaps to a lesser extent. And
certainly, all three of the winners have
had to endure their share of heavy profes-
sional criticism from different segments of
the scientific community over the years.
One problem is that a lot can go wrong
in an MD simulation of a biomolecular
system, and authors publishing the
results can end up looking like chumps.
For a start, the ‘‘model system,’’ i.e., the
atoms included in the calculation, can be
incomplete; the experimental structures
from which simulations started can be
too inaccurate, or can be missing bits.
Moreover, the environment, i.e., the
solvent, including the water molecules
and counterions must be represented
reasonably well, even if some of this infor-
mation is not known from experiments.
Furthermore, the interaction potential (or
‘‘force field’’) used in most simulations is
an empirical compromise that is subject
to several approximations. Finally, there
is often not enough computing power to
exhaustively sample what one is trying
to look at, and simulators have been all
too often tempted to read significance
into isolated anecdotal events.
Even this year’s winners have not been
immune to simulation gremlins. The
Warshel and Levitt study folding BPTI
(Levitt and Warshel, 1975), was later
found to use overly-permissive criteria
for success; a structure superficially
resembling that of native BPTI was
found from a sequence containing only
alanines and glycines (Hagler and Honig,
1978). Levitt’s early papers did notª2013 Elsevier Ltd All rights reserved 2103
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tions, because they were too expensive
to compute. His paper on the simplicity
of the prediction of stability and activity
of a protein core (Lee and Levitt, 1991)
was later criticized; comparable, if not
better, agreement with the experimental
data was reached using much simpler
models based on straightforward struc-
tural considerations, which do not even
require calculations on a computer (van
Gunsteren andMark, 1992). Exacerbating
this type of problem was, and is, the
public in-fighting between experts about
which approach is best and the 1970s
opinions of some theoretical chemistry
purists that simulation is a cop-out,
because we’re not bright enough to figure
out an appropriate analytical theory. The
field of biomolecular simulations has
been, and continues to be, animated by
numerous debates and controversies
regarding the relative value of different
approximations and the significance of
various approaches. Computations are
an ‘‘artifact’’ in the true sense of the
term—they are the product of human
craft—so there is an unavoidable element
of subjectivity in judging them. Getting the
‘‘right’’ answer is nice, but it’s not enough;
one must get it for the right reason, most
theoreticians would argue (and argue
they sure do!). Perhaps, then, we can un-
derstand why it took the Nobel committee
40 years to recognize the field!
The 2013 prize recognizes the sus-
tained, profound effect that computa-
tional modeling and simulation has had
on structural biology. Harnessing statisti-
cal mechanics to connect with macro-
scopic experiments, simulations have
gone much further than simply describing
internal motions. Indeed, these models
provide a formal link between micro-
scopic interactions and thermodynamics.
Using computer ‘‘alchemy’’ has made it
possible to calculate differences in free
energies, entropies, and enthalpies on
changing a ligand binding to a protein
or on mutating an active site; these
methods—pioneered by Arieh Warshel,
AndrewMcCammon, andWilliam Jorgen-
sen in the early 1980s—have been used
in the initial stages of the design of
drugs currently on the market. There is
real promise—with improved force fields
and increased computational power—
that free energy calculations will play an
increasingly important role in the design2104 Structure 21, December 3, 2013 ª2013of drugs in the long term. Simulations
can be used to suggest novel mecha-
nisms or hypotheses about complex pro-
cesses. Another of the wonderful features
of MD is that one can calculate so many
different things from a single simulation.
For example, because of the weak
coupling between experimental radiation
probes (X-rays, neutrons, microwaves,
etc.) and molecular systems, one doesn’t
have to explicitly include the probes in the
simulation itself. That means that one
can calculate, using correlation functions,
many different scattering and spectro-
scopic quantities from a single simulation.
Simulations therefore play a role in unify-
ing different experimental observations
in a single self-consistent physical model.
Methodologies improving simulation
accuracy and speed have proliferated.
Conformational sampling, the difficulty of
which increases exponentially with chain
length, provides grist for the theoretician’s
mill. Techniques such as simulated
annealing (in the 1980s) and parallel
tempering and adaptive biasing (nowa-
days) were adopted. Furthermore, the
massive increase in computer power
since the 1970s and the development of
a new generation of highly performing
simulation programs such as NAMD
(Phillips et al., 2005) have enabled the
useful atomic-detail simulation of large
proteins and protein complexes, protein:
DNA interactions, membranes, receptors,
and ion channels. The outer MD limits,
which were a few picoseconds for 100
atoms in 1975, are now about one micro-
second for 100 million atoms on a highly-
parallel supercomputer (Figure 1B), and
when the exascale of computing power
is reached, we will, in principle, have the
capacity to simulate a whole living cell at
atomic detail. Work will also be performed
sitting on the Cloud. The special purpose-
built Anton supercomputer (Shaw et al.,
2009) has extended MD capabilities to a
millisecond, and thus a further raft of
atomic detail biological phenomena
moves into view. In another form of multi-
scale, coarse-graining potentials allow
further spatiotemporal extension, and
feelers are being extended to systems
biology tools such as metabolic network
and cell-compartment simulations.
A profound mechanistic understanding
of biomolecular systems will be recog-
nized by our ability to make quantitatively
accurate and reliable predictions ofElsevier Ltd All rights reservedstructure, dynamics, and function from
computational models. While simplified
‘‘toy’’ models and back-of-the-envelope
theories have played and continue to
play an important role in formulating
new concepts or elaborating new strate-
gies, there is an increasing need for the
‘‘virtual reality’’ provided by simulations
to quantitatively match, with some
reasonable accuracy, what can happen
in the real world. Thus, even if the
simulations are not perfect, we would
like to be sure that the ‘‘correct’’ answer
falls reliably and predictably within
some interval around the computational
result. Achieving such reliability is criti-
cally important for consolidating the
usefulness of molecular simulation in the
biomedical sciences. Confidence that
simulations provide true, genuine infor-
mation about the system under study
has important implications. For example,
when the result of a computation does
not match some experimental measure-
ment, then one should be able to
conclude that it is not the calculation but
some underlying hypothesis about the
system that is wrong. This situation is
similar to the case in which two types of
experiments, e.g., solution NMR and
X-ray crystallography, appear to disagree
with each other. In this case, one does not
immediately conclude that one of them is
‘‘wrong,’’ but rather that the structure in
solution must be different than that in the
crystalline form. This becomes possible
when one knows that the computation,
while not perfect, has systematic reli-
ability in accomplishing a specific task.
Confidence in the general correctness of
simulations does exist for some types of
calculations for which there have been
extensive previous experience and vali-
dation. In those cases, the results of com-
puter simulations can already be used to
unequivocally confirm or refute specific
hypotheses that resist other modes of
investigation.
But the field of simulations is still rough
around the edges, a work in progress.
Simulation inaccuracies have dogged
for decades the relationship between
simulation and experiment in structural
biology. As a result, the field has been
plagued by a distrust of predictions.
Whereas an elegantly constructed theory
in physics often triggers interest prior to
experimental testing, wariness of theory
is prevalent in biology. Evolution away
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process. As noted by Karplus in his
autobiographical review (Karplus, 2006),
if a theory agrees with experiment, it is
not interesting because the result is
already known, whereas if one is making
a prediction, then it is not publishable
because there is no experimental evi-
dence that the prediction is correct. The
mindset that must be adopted to achieve
systematic reliability, so that prediction
can stand on its own two feet, is akin to
sculpture or engineering, requiring sys-
tematic efforts at chipping away, clean-
ing, and polishing. We must improve
force fields, establish standardized best
practices in simulation methodology and
free energy computations, develop effec-
tive sampling strategies, etc.
Perhaps, though, the singular ability of
numerical simulation to furnish a firm
energetic and thermodynamic foundation
for the formation and functional use of
three-dimensional structure meant thatit was inevitable that this field would
slowly but surely take a hold in molecular
biophysics. At any rate, there’s no turning
back. Computations are at the forefront
of modern-day scientific planning, and
simulation is now firmly established as
the third pillar of science, linking experi-
ment to theory for complex systems
resisting the back of an envelope calcula-
tions. For all their infuriating aspects,
maybe accurate computer simulations
are indeed the only way to unlock a
deep understanding of how a biological
system works.
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